Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.36
Aug. 08, 2025 16:00:00- Change -0.0202 (-5.35667%)
- Volume 2,715,077
- Today's Open 0.3627
- Previous Close 0.3771
- Today's High 0.37
- Today's Low 0.345
- 52 Week High 4.3
- 52 Week Low 0.335